In a market that is infused with headwinds coming from China, Russia and Europe, there is always one group that Jim Cramer can count on: Biotech.In fact, Cramer has been in a heated love affair with biotech for more than 30 years. While you don’t get a rally from them every day, he thinks they are more reliable than any […]
Once again, deals and collaborations made news in the biotech sector with BioMarin (BMRN – Analyst Report) announcing its intention to acquire Prosensa (RNA – Snapshot Report) and Five Prime Therapeutics (FPRX – Snapshot Report) signing a second immuno-oncology focused deal with Bristol-Myers Squibb.Meanwhile, AbbVie (ABBV – Analyst Report) continues to progress with its hepatitis C virus (HCV) treatment with […]
Benchmarks settled in the green as investors continued to be encouraged by efforts from China and Europe to boost their economies. Retail stocks surged as investors believe lower gasoline prices will boost retail sales this holiday season. The S&P 500 and the Dow yet again closed at record highs. Separately, a rally among bio-tech stocks and tech-giant Apple boosted the […]
Year end is coming up quickly, and that has investors pouring over portfolios, dissecting financial reports, and considering names to own heading into 2015. ;With that in mind, read on to learn why ;I think these three biotech stocks may prove worthy enough of investor wish-lists next month.Source: Cubist Pharmaceuticals1. Treating hospital infectionsOn December 21, the FDA will make a […]
That bright neon sign you’re looking at are biotech stocks flashing, “Buy me!”So put down your morning joe. Go ahead, do it. And ignore all incoming e-mail for the next few minutes. Because the biotech breakout has arrived — and it can make you a bundle over the next few months.That’s right. Forget about this month’s stock roller-coaster ride. Yeah, sure, it […]
While biotech stocks saw an early selloff Friday, the shares of three companies in the sector have plenty of potential left, John Schroer of Allianz Global Investors said on CNBC.Biogen Idec is his top pick.”Leading company in the [multiple sclerosis] space. They have some very strong earnings growth, 20 to 25 percent earnings growth over the next three years. And […]
The S&P 500 closed at a record high and fellow benchmarks also ended in the green boosted by deal news. Possibility of stimulus measures in the Eurozone also lifted the benchmarks. The S&P crossed the 2000-point milestone for the first time, but failed to end above that mark. However, full day trading volume was the lowest this year.For a look […]
The Voynich Manuscript might have been dropped to Earth by aliens; it might be a medieval cipher whose mystery outlived anyone who had the key; it also might be a prank and moneymaking scheme by some haggard rare bookseller. But whatever the book actually is, Brazilian scientists are pretty certain that the manuscript’s text—which is written in a language and […]
In the age of big data, visualization tools are vital. With a single glance at a graphic display, a human being can recognize patterns that a computer might fail to find even after hours of analysis.But what if there are aberrations in the patterns? Or what if there’s just a suggestion of a visual pattern that’s not distinct enough to […]
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers. Disappointing retail sales also negated concerns about a sooner-than-expected interest rate hike. Healthcare and technology stocks helped the S&P to hit a two-week high. However, disappointing earnings from Macy’s eroded some of yesterday’s gains.For a look at the issues currently facing the markets, make sure […]
